Here’s a roundup of companies announcing new distribution deals.

• BD and UCL Business sign exclusive license agreement to advance development of diagnostic tests for ovarian and breast cancers
  UCL Business, a wholly owned subsidiary of University College London, and Becton, Dickinson & Co. (NYSE:BDX), a global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment.
  Read more
• ThermoGenesis announces agreement for AXP and bioArchive cord blood systems with Chinese stem cell firm
  ThermoGenesis Corp. (NSDQ:KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today it has signed a product purchase agreement with Beike Biotechnology Co. Ltd., a stem cell and regenerative medicine company in China. Under the agreement, ThermoGenesis will supply Beike with an initial stocking in fiscal 2011 of its AXP AutoXpress and BioArchive Systems used in the processing and storage of stem cells from cord blood. Beike is headquartered in Shenzhen, Guangdong Province, and has offices in several China cities, including the China Medical City. Beike produces a full line of products derived from umbilical cord tissue, cord blood and bone marrow stem cells.
  Read more
• Luminex and Partners HealthCare announce collaboration
  Luminex Corp. (NSDQ:LMNX) announced today that it has teamed with Partners HealthCare toward the discovery of novel biomarkers and development of clinical assays. This program will enable Partners HealthCare Center for Personalized Genetic Medicine (PCPGM) to develop novel molecular diagnostic assays based on biomarkers discovered within Partners HealthCare entities. These innovative tests will operate on Luminex’s proprietary xMAP testing platform. Under the terms of the agreement, Luminex and PCPGM will evaluate opportunities for novel assays which will be developed and validated in the PCPGM’s CLIA-certified Laboratory for Molecular Medicine.
  Read more
• SwitchGear Genomics announces distribution agreement with BioCat GmbH
  SwitchGear Genomics Inc., a provider of products for studying the regulatory elements in the human genome, today announced that the company signed an agreement for BioCat GmbH to distribute the innovative LightSwitch Luciferase Assay System in Europe. The system consists of a full reporter assay solution including a genome-wide collection of human promoter and 3’UTR luciferase reporters and optimized luciferase assay reagents for measuring transcriptional activation and translational efficiency in living cells.
  Read more
• DJO Global and Lima Corporate expand U.S. partnership
  DJO Global Inc., a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, and Lima Corporate, a European-based orthopedic implants company, announced today that DJO Surgical, a DJO Global business unit, has reached an agreement with Lima Corporate for an expanded partnership for the United States implant market.
  Read more

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW